D.E. Shaw & Co
SLDB icon

D.E. Shaw & Co’s Solid Biosciences SLDB Stock Holding History

D.E. Shaw & Co’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Buy
222,789
+94,441
+74% +$716K ﹤0.01% 3106
2026
Q1 		$924K Buy
128,348
+88
+0.1% +$565 ﹤0.01% 3493
2025
Q4 		$723K Buy
+128,260
New +$695K ﹤0.01% 3735
2025
Q1 		– Sell
-51,972
Closed -$208K – 4703
2024
Q4 		$208K Buy
+51,972
New +$285K ﹤0.01% 4068
2021
Q4 		– Sell
-1,312
Closed -$47K – 5689
2021
Q3 		$47K Sell
1,312
-3,227
-71% -$137K ﹤0.01% 4830
2021
Q2 		$249K Buy
4,539
+3,440
+313% +$227K ﹤0.01% 4359
2021
Q1 		$91K Sell
1,099
-13,992
-93% -$1.55M ﹤0.01% 3938
2020
Q4 		$1.72M Sell
15,091
-4,478
-23% -$283K ﹤0.01% 2650
2020
Q3 		$596K Sell
19,569
-4,326
-18% -$166K ﹤0.01% 3137
2020
Q2 		$1.05M Buy
23,895
+3,474
+17% +$144K ﹤0.01% 2895
2020
Q1 		$732K Buy
20,421
+2,787
+16% +$138K ﹤0.01% 2977
2019
Q4 		$1.18M Buy
17,634
+12,466
+241% +$1.38M ﹤0.01% 2871
2019
Q3 		$802K Buy
+5,168
New +$585K ﹤0.01% 2943
2018
Q4 		– Sell
-2,302
Closed -$1.63M – 3968
2018
Q3 		$1.63M Sell
2,302
-1,168
-34% -$734K ﹤0.01% 2346
2018
Q2 		$1.85M Buy
3,470
+1,867
+116% +$574K ﹤0.01% 2276
2018
Q1 		$180K Buy
+1,603
New +$541K ﹤0.01% 3346

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co's SLDB Position: Q2 2026 in Review

D.E. Shaw & Co increased its Solid Biosciences (SLDB) stake by 74% in Q2 2026, buying an estimated $716K and bringing the position to 222,789 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

D.E. Shaw & Co first reported a position in SLDB in Q1 2018 and has held it in 16 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • D.E. Shaw & Co held 222,789 shares of Solid Biosciences worth $2.23M as of Q2 2026.
  • D.E. Shaw & Co bought 94,441 Solid Biosciences shares in Q2 2026, an estimated $716K.
  • Solid Biosciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #3106 holding.
  • D.E. Shaw & Co first reported a position in Solid Biosciences in Q1 2018 and has held it in 16 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.